During our screening of gliding bacteria for new antibiotics, the myxobacterium Angiococcus disciformis strain An d30 was found to produce activity against fungi and bacteria. Part of the activity appeared in the culture supernatant, part within the cell mass. The activity could be extracted with ethyl acetate and acetone, respectively. Preliminary experiments showed that the activity was due to different antibiotics. One of the compounds, which was mainly found in the cell extracts, could be identified with myxothiazol, an antifungal antibiotic, which had been isolated before in our laboratory from the myxobacterium Myxococcus fulvus strain Mx f161 . A second activity, which was mainly in the culture supernatant inhibited the growth of a few Gram-positive bacteria and of Escherichia coli mutants with increased permeability. It proved to be a new antibiotic, consisting of several components, and the main component was named angiolam A (Fig. 1) . A third substance with weak antibacterial activity was also new and is still under investigation.
In this article we report on the production, isolation and on some physico-chemical and biological properties of angiolam A, while the structure determination is published elsewhere'). tures of 100-m1 or 500-ml in 250-m1 or 1,000-m1 Erlenmeyer flasks, respectively, were incubated at In Probion liquid medium the yield of angiolam A was 4-5 times higher than in peptone liquid medium.
Cell suspensions in peptone liquid medium could be preserved by storing at -80°C or in liquid nitrogen.
Production
For mass production of angiolam A, fermentations were performed in Probion liquid medium The pO2 in the culture was recorded continuously with a polarographic oxygen electrode. At the beginning of the fermentation it was at about 90% saturation , it fell within the first 16 hours to about 20Y. and was then adjusted to 30% by increasing the aeration rate . Towards the end of the fermentation at 37 hours, the pO2 rose to 45 %. The antibiotic activity was monitored during the fermentation by the paper disc diffusion assay using Escherichia coli K 12 W 495 as test organism , and further was quantitatively determined by HPLC analysis (columns; 7 ,urn Lichrosorb RP-18, 25 cm x 4 mm (Merck, Darmstadt), solvent; methanol -water, 65: 35). At the end of the fermentation the concentration of angiolam A was 5.8 mg/liter. Over 90% of the antibiotic was adsorbed to the resin.
Isolation
The adsorber resin was separated from the culture by passing the content of the fermentor through a sieve of 0.25 mm pore size. The resin was then transferred into a chromatography column of 10-cm diameter and washed with 20 liters of methanol -water (40: 60). The crude antibiotic was then eluted with 40 liters of methanol -water (90: 10) and purified by different chromatography steps (Sephadex LH-20; silica gel 100) and distribution between water and heptane. Further details of the purification procedure will appear elsewhere'). anisaldehyde and 2 % sulfuric acid and heating at 110°C the antibiotic gave a blue-violet spot.
A negative ion fast-atom bombardment mass spectrum showed a (M-H) ion at 586 mass units which together with the elemental analysis, established the molecular formula C,4H5,NO,. The electronic absorption spectrum of angiolam A in methanol recorded with a Zeiss DMR 21 spectrophotometer had a maximum at 227 nm (log e 4.29) (Fig. 2) . The IR spectrum was measured in KBr with a Perkin Elmer 297 IR spectrometer (Fig. 3) , and the 13C NMR in de uteriochloroform with a NMR spectrometer WH 400 at 100.6 MHz (Bruker, Karsruhe) (Fig. 4) . The result of the structure elucidation" is shown in Fig. 1 .
Biological Properties
The antimicrobial spectrum of angiolam A was determined by the agar diffusion test using paper discs (Table 1) 
Discussion
Angiococcus disciformis strain An d30 is the second myxobacterium after Stigmatella auantiaca strain Sg a15" which we found to produce several structurally unrelated antibiotics. The antifungal compound, myxothiazo11-3?, which was first isolated from Myxococcus fulvus strain Mx f 16, has a bisthiazol system and was produced by A. disciformis up to 6 mg/liter. Angiolam A is a new macrocyclic lactone-lactam antibiotic and was produced by A. disciformis up to about 6 mg/liter. In some fermentations minor amounts of angiolam A derivatives also were detected. While the antibiotics from Stiginatella aurantiaca strain Sg a15 all interfere with the respiration','', the antibiotics from An d30 show quite different biological properties. Myxothiazol is mainly an antifungal antibiotic and selectively inhibits the cytochrome b-c1 segment of the respiratory chain'). Angiolam A is active against only a few bacteria. The insensitivity of most bacteria is probably due to an impermeability of their cell wall for angiolam A. This is suggested a) by the sensitivity of E. coli strains with increased permeability, and b) by the sensitivity of a stable protoplast-L-form of Proteus nrirabilis VI which as an intact organism was totally resistant. Angiolam A appears to interfere with the prokaryotic protein synthesis. It shows no acute toxicity for mice. It might be possible to synthesize derivatives of angiolam A, with a broader antimicrobial spectrum. •: At the time indicated by the arrow the antibiotic (3 ipg/ml) was added to the culture. 0: Control culture without antibiotic. 
